Auganix.org
  • News
    • Augmented Reality News
    • Virtual Reality News
    • All Categories
  • Contracts
  • HUD
  • Reports
  • Contact
Latest News
  • [ April 9, 2021 ] Wallace State Community College utilizing Virtual Reality to train workers for roles in diesel tech jobs 2021
  • [ April 8, 2021 ] US go-karting chain Autobahn Indoor Speedway signs purchase agreement with Immersive Tech for up to 10 Virtual Reality LBE attractions 2021
  • [ April 8, 2021 ] Samsung Galaxy SmartTag+ allows users to find lost items using Augmented Reality 2021
  • [ April 7, 2021 ] New Zealand-based Augmented Reality app homeAR raises $750,000 and launches v2.0 of its home viewing platform 2021
  • [ April 7, 2021 ] Nextech AR launches its new Digital Experience Platform ‘Nextech AR LiveX’ 2021
  • Twitter
  • LinkedIn
  • Facebook
  • Google

WorldViz Partners with University of British Columbia on VR balance research

March 6, 2019 2019, Canada, Collaborations & Partnerships, Education & Training, Healthcare, News, North America, Platform, Software, Virtual Reality News

March 6, 2019 – WorldViz has today announced a new partnership with the The Origins of Balance Deficits and Falls (OBDAF) Research Cluster of University of British Columbia (UBC) in Canada. Researchers within this cluster study the mechanistic principles of healthy balance control and origins of balance deficits and falls.

The OBDAF Research Cluster’s work is used for developing new tools, therapeutic interventions and technologies to reduce the likelihood and impact of balance instability and falls. The cluster consists of over 35 members from across 6 departments at UBC and a wide network of institutions across Canada, the US, Europe and Australia. Cluster members study human balance and mobility and conduct research that aims to understand the origins of balance deficits and falls. Research focuses on the sensori-motor, orthopaedic, psychological and neurological factors that contribute to fall risk in older adults and individuals with Parkinson’s Disease, multiple sclerosis, vestibular loss, spinal cord and traumatic brain injury.

In research and development, WorldViz VR solutions, namely the WorldViz Vizard VR platform, enable experimental setups that would not be possible in the real world, while at the same time ensuring experimental control. Users can create controlled and repeatable simulations and experiments where reality can be simulated to capture results. Analysis of the physiological data obtained can then be automated.

Vizard also allows for these simulations to be connected to VR headsets, CAVEs and Powerwalls, head/hand motion trackers and motion capture systems, and specialty devices such as eye trackers, haptic feedback devices, and biophysical sensors such as EEGs, EKGs and GSRs. Data collection, analysis, and full experimental control are possible through Vizard’s Python-based coding interface and layout of modules for scientific research.

WorldViz stated that as part of this partnership, it is offering all cluster members a discount for Vizard VR software purchases. To allow members to replicate/expand on existing research from Professor Mark Carpenter at UBC, WorldViz is offering to sell Vizard Enterprise Edition licenses for the price of the Vizard Development Edition.

Image credit: WorldViz

Share this article

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Reddit (Opens in new window)

About the author

Sam Sprigg
Managing Editor

Sam is the Founder and Managing Editor of Auganix. With a background in research and report writing, he covers news articles on both the AR and VR industries. He also has an interest in human augmentation technology as a whole, and does not just limit his learning specifically to the visual experience side of things.

Related Posts

  • AppliedVR receives FDA Breakthrough Device designation to treat pain with its VR digital therapeutic platform
    AppliedVR receives FDA Breakthrough Device designation to treat pain with its…
  • AppliedVR announces $29 Million in Series A funding as it pursues full FDA approval for its therapeutic VR solution
    AppliedVR announces $29 Million in Series A funding as it pursues full FDA…
  • MIT.nano announces the opening of its Immersion Lab for AR and VR-based research
    MIT.nano announces the opening of its Immersion Lab for AR and VR-based research
  • Qualcomm XR Enterprise Program doubles roster of AR and VR solutions providers in first year
    Qualcomm XR Enterprise Program doubles roster of AR and VR solutions…
Previous

Wikitude announces Nicola Radacher as new COO

Next

Subvrsive announces Lens.io platform for app-less AR experiences

Reality Check

  • Qualcomm announces its new Snapdragon XR1 AR Smart Viewer Reference Design

    February 23, 2021
    In Augmented Reality and Mixed Reality News February 23, 2021 – Qualcomm Technologies, Inc. has today introduced its first augmented reality (AR) ...

Featured HUD Profile

Samsung logo
Samsung logo

News Showcase

Spatial announces significant updates to its VR collaboration platform and aims to make it “as ubiquitous as Google Docs”

Morehouse College launches Virtual Reality campus and classes in collaboration with VictoryXR and Qualcomm

UK Ministry of Defence goes to tender for virtual training and simulation contract worth up to £30 million

Arvizio launches its Immerse 3D solution for sharing 3D models in AR within collaborative web meeting platforms

SPREE Interactive secures multimillion Euro investment to expand its global partnerships and free-roam VR eSports experiences

CommonWealth Partners using AK Preparedness’ Virtual Reality fire drill solution for its Pier 4 property in Boston

About
  • About Auganix
  • Privacy policy
Advertise
  • Advertise with us
News Archives
Social Media & RSS
  • Twitter
  • LinkedIn
  • Google

Copyright © 2020 Auganix Ltd.

This website uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.